Brief: Marksans Pharma Re-Appointed Mark Saldanha As MD
25/07/2025 14:18
July 25 (Reuters) - Marksans Pharma Ltd MARK.NS: MARKSANS PHARMA - RE-APPOINTED MARK SALDANHA AS MD Source text: ID:nnAZN49KIRS Further company coverage: MARK.NS ((reuters.briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg